메뉴 건너뛰기




Volumn 1, Issue 3, 2000, Pages 234-239

ACE inhibitors and antihypertensive treatment in diabetes: Focus on microalbuminuria and macrovascular disease

Author keywords

ACE inhibition; AT receptor blockade; Blood pressure; Diabetes mellitus; Diabetic nephropathy; Glomerulopathy; Hypertension; Macrovascular disease; Microalbuminuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EID: 0034285957     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2000.035     Document Type: Review
Times cited : (5)

References (34)
  • 1
    • 50449132190 scopus 로고
    • Diabetic angiopathy, a specific vascular disease
    • Lundbæk K. Diabetic angiopathy, a specific vascular disease. Lancet 1954; 1: 377-9.
    • (1954) Lancet , vol.1 , pp. 377-379
    • Lundbæk, K.1
  • 2
    • 0000072168 scopus 로고    scopus 로고
    • Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas
    • Mogensen CE (ed.) Boston, Dordrecht, London. Kluwer Academic Publishers
    • Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas. In Mogensen CE (ed.) The Kidney and Hypertension in Diabetes Mellitus, 5th ed. Boston, Dordrecht, London. Kluwer Academic Publishers, 2000:655-706.
    • (2000) The Kidney and Hypertension in Diabetes Mellitus, 5th Ed. , pp. 655-706
    • Mogensen, C.E.1
  • 3
    • 0032511558 scopus 로고    scopus 로고
    • Combined high blood pressure and glucose in type 2 diabetes: Double Jeopardy
    • Mogensen CE. Combined high blood pressure and glucose in type 2 diabetes: Double Jeopardy. BMJ 1998; 317: 693-4.
    • (1998) BMJ , vol.317 , pp. 693-694
    • Mogensen, C.E.1
  • 4
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients
    • The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients. New Engl J Med 2000; 342: 145-53.
    • (2000) New Engl J Med , vol.342 , pp. 145-153
  • 5
    • 0034700790 scopus 로고    scopus 로고
    • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
    • Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9.
    • (2000) Lancet , vol.355 , pp. 253-259
  • 6
    • 0034628425 scopus 로고    scopus 로고
    • Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
    • The Diabetes Control and Complications Trial Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381-9.
    • (2000) N Engl J Med , vol.342 , pp. 381-389
  • 7
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38
    • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38. BMJ 1998; 317:703-13.
    • (1998) BMJ , vol.317 , pp. 703-713
  • 8
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 13:1755-62.
    • (1998) Lancet , vol.13 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 9
    • 0033055724 scopus 로고    scopus 로고
    • Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
    • Gæde P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study. Lancet 1999; 353: 617-22.
    • (1999) Lancet , vol.353 , pp. 617-622
    • Gæde, P.1    Vedel, P.2    Parving, H.-H.3    Pedersen, O.4
  • 10
    • 0033069767 scopus 로고    scopus 로고
    • 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension
    • Guidelines subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17:151-83.
    • (1999) J Hypertens , vol.17 , pp. 151-183
  • 11
    • 0033034404 scopus 로고    scopus 로고
    • Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The captopril Prevention Project (CAPPP) randomised trial
    • Hansson L, Lindholm LH, Niskanen L et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353:611-16.
    • (1999) Lancet , vol.353 , pp. 611-616
    • Hansson, L.1    Lindholm, L.H.2    Niskanen, L.3
  • 12
    • 0032485350 scopus 로고    scopus 로고
    • The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
    • Estacio RO, Jeffers BW, Hiatt WR et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338:645-53.
    • (1998) N Engl J Med , vol.338 , pp. 645-653
    • Estacio, R.O.1    Jeffers, B.W.2    Hiatt, W.R.3
  • 13
    • 0033522149 scopus 로고    scopus 로고
    • Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
    • Toumilehto J, Rastenyte D, Birkenhäger W et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340; 677-84.
    • (1999) N Engl J Med , vol.340 , pp. 677-684
    • Toumilehto, J.1    Rastenyte, D.2    Birkenhäger, W.3
  • 14
    • 0033589756 scopus 로고    scopus 로고
    • Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
    • Hansson L, Lindholm LH, Ekbom T et al. for the STOP-Hypertension-2 study Group. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354:1751-6.
    • (1999) Lancet , vol.354 , pp. 1751-1756
    • Hansson, L.1    Lindholm, L.H.2    Ekbom, T.3
  • 15
    • 85088333898 scopus 로고    scopus 로고
    • Randomised controlled trial of dual blockade of the renin-angiotensin system in hypertensive, microalbuminuric, non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
    • (Submitted for publication)
    • Mogensen CE, Neldam S, Tikkannen I et al. for the CALM Study Group. Randomised controlled trial of dual blockade of the renin-angiotensin system in hypertensive, microalbuminuric, non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000. (Submitted for publication)
    • (2000) BMJ
    • Mogensen, C.E.1    Neldam, S.2    Tikkannen, I.3
  • 16
    • 0021236983 scopus 로고
    • Predicting diabetic nephropathy in insulin-dependent patients
    • Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311:89-93.
    • (1984) N Engl J Med , vol.311 , pp. 89-93
    • Mogensen, C.E.1    Christensen, C.K.2
  • 17
    • 0026731377 scopus 로고
    • Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes
    • Mogensen CE, Østerby R, Hansen KW, Damsgaard EM. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992; 15: 1192-204.
    • (1992) Diabetes Care , vol.15 , pp. 1192-1204
    • Mogensen, C.E.1    Østerby, R.2    Hansen, K.W.3    Damsgaard, E.M.4
  • 18
    • 0028867689 scopus 로고
    • Prevention of diabetic renal disease with special reference to microalbuminuria
    • Mogensen CE, Keane WF, Bennett PH et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080-4.
    • (1995) Lancet , vol.346 , pp. 1080-1084
    • Mogensen, C.E.1    Keane, W.F.2    Bennett, P.H.3
  • 19
    • 0029279966 scopus 로고
    • Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion
    • Mogensen CE, Vestbo E, Poulsen PL et al. Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 1995; 18: 572-81.
    • (1995) Diabetes Care , vol.18 , pp. 572-581
    • Mogensen, C.E.1    Vestbo, E.2    Poulsen, P.L.3
  • 20
    • 0028011891 scopus 로고
    • Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
    • Viberti GC, Mogensen CE, Groop L, Pauls JF for the European Microalbuminuria Captopril Study Group. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271: 275-9.
    • (1994) JAMA , vol.271 , pp. 275-279
    • Viberti, G.C.1    Mogensen, C.E.2    Groop, L.3    Pauls, J.F.4
  • 21
    • 0028860451 scopus 로고
    • The beneficial effect of angiotensin-converting-enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria
    • Laffel LMB, McGill JB, Gans DJ on behalf of the North American Microalbuminuria Study Group. The beneficial effect of angiotensin-converting-enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995; 99: 497-504.
    • (1995) Am J Med , vol.99 , pp. 497-504
    • Laffel, L.M.B.1    McGill, J.B.2    Gans, D.J.3
  • 22
    • 0030908772 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
    • The Euclid Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-92.
    • (1997) Lancet , vol.349 , pp. 1787-1792
  • 23
    • 0001160284 scopus 로고    scopus 로고
    • ACE inhibition during two years did not improve urinary excretion in normotensive microalbuminuric patients
    • Bojestig M, Karlberg B, Verho M and the Prima Study Group. ACE inhibition during two years did not improve urinary excretion in normotensive microalbuminuric patients. Diabetologia 1998; 41: A544.
    • (1998) Diabetologia , vol.41
    • Bojestig, M.1    Karlberg, B.2    Verho, M.3
  • 25
    • 0033519752 scopus 로고    scopus 로고
    • Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria
    • Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving H-H. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 1999; 319; 24-5.
    • (1999) BMJ , vol.319 , pp. 24-25
    • Mathiesen, E.R.1    Hommel, E.2    Hansen, H.P.3    Smidt, U.M.4    Parving, H.-H.5
  • 26
    • 0346879995 scopus 로고    scopus 로고
    • ACE inhibition vs. calcium-channel blockade in normotensive type 1 and type 2 diabetic patients with microalbuminuria
    • Jerums G on behalf of the Melbourne Diabetic Nephropathy Study Group, Melbourne, Australia. ACE inhibition vs. calcium-channel blockade in normotensive type 1 and type 2 diabetic patients with microalbuminuria. Nephrology Dial Trans 1998; 13: 1065-66.
    • (1998) Nephrology Dial Trans , vol.13 , pp. 1065-1066
    • Jerums, G.1
  • 27
    • 0347510523 scopus 로고    scopus 로고
    • Early ACE-I intervention in microalbuminuria: 24h BP, renal function and exercise changes. Abstract of the 34th Annual Meeting of the EASD Barcelona, Spain 8-12 Sept. 1998
    • Ebbehoj E, Poulsen PL, Nosadini R, Fioretto R, Fioretto P, Crepaldi C, Mogensen CE. Early ACE-I intervention in microalbuminuria: 24h BP, renal function and exercise changes. Abstract of the 34th Annual Meeting of the EASD Barcelona, Spain 8-12 Sept. 1998. Diabetologia 1998; 41(1).
    • (1998) Diabetologia , vol.41 , Issue.1
    • Ebbehoj, E.1    Poulsen, P.L.2    Nosadini, R.3    Fioretto, R.4    Fioretto, P.5    Crepaldi, C.6    Mogensen, C.E.7
  • 28
    • 0032967512 scopus 로고    scopus 로고
    • Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type 1 (insulin-dependent) diabetes mellitus
    • Rudberg S, Østerby R, Bangstad H-J, Dahlquiest G, Persson B. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1999; 42: 589-95.
    • (1999) Diabetologia , vol.42 , pp. 589-595
    • Rudberg, S.1    Østerby, R.2    Bangstad, H.-J.3    Dahlquiest, G.4    Persson, B.5
  • 30
    • 0343522604 scopus 로고
    • The effect of angiotensin converting enzyme inhibition on diabetic nephropathy
    • Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 118: 577-81.
    • (1993) N Engl J Med , vol.118 , pp. 577-581
    • Lewis, E.J.1    Hunsicker, L.G.2    Bain, R.P.3    Rohde, R.D.4
  • 32
    • 0019965181 scopus 로고
    • Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
    • Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982; 285:685-8.
    • (1982) BMJ , vol.285 , pp. 685-688
    • Mogensen, C.E.1
  • 33
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
    • Stratton IM, Adler AI, Neil AW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, A.W.3
  • 34
    • 0034641550 scopus 로고    scopus 로고
    • Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
    • Adler AI, Stratton IM, Neil AW et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9.
    • (2000) BMJ , vol.321 , pp. 412-419
    • Adler, A.I.1    Stratton, I.M.2    Neil, A.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.